Biocon Biologics
Anshuman Dey has extensive experience in clinical trial quality assurance, currently serving as Associate Manager in the Clinical Trial QA team at Biocon Biologics since July 2021, after progressing from Deputy Manager in the same team. Prior to this, Anshuman held the position of Assistant Manager at Biocon (November 2017 - July 2021), performing audits, maintaining quality systems, and ensuring compliance with regulations. Anshuman's career also includes roles as Quality Assurance Auditor at IQVIA, Clinical Trial Quality Assurance Auditor at CLINOGENT, Team Leader in Clinical Operations at Embrace Innovations, and Assistant Manager in Research Quality Assurance at Cadila Pharmaceuticals. Anshuman Dey holds a PGDCRA degree in Clinical Research and a Master’s degree in Zoology from Visva-Bharati University.
Biocon Biologics
8 followers
Biocon Biologics Limited, a subsidiary of Biocon Limited, is a fully integrated global biosimilars organization. It is leveraging cutting-edge science, innovative tech platforms and advanced research & development capabilities to lower treatment costs while improving healthcare outcomes. It has a strong research pipeline of biosimilar molecules across diabetes, oncology, immunology, and other non-communicable diseases. Six molecules from Biocon Biologics’ portfolio have been taken from lab to market in developed markets like United States, EU, Australia, Canada and Japan. With a team of ~ 4,800 people, Biocon Biologics is committed to transforming healthcare and transforming lives by enabling affordable access to millions of patients’ worldwide. Follow-us on Twitter: @BioconBiologics